Healthy Inc > Blog > Zidovudine manufacturer India
Posted on:

Why is zidovudine no longer used?

It is a common misconception in the pharmaceutical industry that Zidovudine (AZT) is no longer used. In reality, Zidovudine remains a critical, life-saving component of HIV therapy, though its role has shifted from a “first-line general treatment” to a “specialized clinical tool.”

As a pharmacist and manufacturer at your WHO-GMP facility in Mumbai, I view Zidovudine as the “Grandfather of Antiretrovirals.” While newer drugs like Tenofovir have replaced it for daily adult maintenance due to better tolerability, Zidovudine is still the gold standard for preventing mother-to-child transmission.

The Shift in Clinical Status: Why it is used less

In the 1980s and 90s, AZT was the only option. Today, it has been moved to “Alternative” or “Second-line” status for most adults for several technical reasons.

FactorTechnical ChallengeModern Alternative
Hematologic ToxicityCauses severe Bone Marrow Suppression, leading to anemia and neutropenia.Tenofovir (TDF/TAF): Much lower impact on blood counts.
Mitochondrial ToxicityInhibits DNA polymerase-gamma, causing Lipoatrophy (fat loss in the face/limbs) and lactic acidosis.Abacavir / Emtricitabine: Fewer metabolic side effects.
Pill BurdenRequires twice-daily (BID) dosing, whereas newer agents are once-daily (QD).Dolutegravir: Part of a highly potent, once-daily single-tablet regimen (STR).
ResistanceHIV develops resistance to AZT relatively quickly if used as monotherapy.Integrase Inhibitors: Higher genetic barrier to resistance.

Where Zidovudine is STILL Essential (2026 Guidelines)

Zidovudine remains irreplaceable in specific B2B and clinical niches that your Mumbai facility likely services:

Prevention of Mother-to-Child Transmission (PMTCT): It is the primary drug used intravenously during labor and orally for the newborn for the first 4–6 weeks of life to prevent HIV infection.

Post-Exposure Prophylaxis (PEP): Often included in “starter kits” for healthcare workers or individuals exposed to HIV.

Salvage Therapy: Used for patients who have developed multi-drug resistance to newer classes of antiretrovirals.

Mechanism: Nucleoside Reverse Transcriptase Inhibition (NRTI)

Zidovudine works through a process called “Chain Termination”:

Phosphorylation: Once inside the cell, AZT is converted by cellular enzymes into its active form, Zidovudine Triphosphate.

Viral Mimicry: The HIV enzyme Reverse Transcriptase mistakes AZT for a natural building block (Thymidine) of DNA.

DNA Blockade: Once AZT is incorporated into the growing viral DNA strand, it lacks the necessary chemical hook (3′-OH group) to attach the next building block. The DNA strand “breaks,” and the virus cannot replicate.

The Pharmacist’s “Technical Warning”

  • The “CBC” Mandate: As a pharmacist, I must emphasize that any patient on Zidovudine needs a Complete Blood Count (CBC) every 2–4 weeks initially. Severe anemia can develop rapidly.

  • Avoid Stavudine (d4T): Zidovudine should never be combined with Stavudine, as they compete for the same phosphorylation pathway, making both drugs ineffective.

    Lactic Acidosis: Watch for unexplained fatigue or hyperventilation, which could be signs of rare but fatal lactic acidosis.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Pediatric Syrup” USP: On your digital platforms, highlight your Zidovudine Oral Solution. This is a high-demand SKU for international health tenders (Global Fund/PEPFAR) specifically for neonatal HIV prevention.

  • FDC Strategy: Most of your B2B volume likely comes from Fixed-Dose Combinations (FDCs) like Lamivudine + Zidovudine (Combivir generic). This remains a vital second-line option in many emerging markets.

  • Stability for Export: Zidovudine is light-sensitive. Utilizing Amber HDPE bottles or Alu-Alu blisters ensures a 36-month shelf life in Zone IVb regions.

Zidovudine Tablet

Posted on:

What is the use of Zidovudine Tablet?

In the pharmaceutical industry, Zidovudine (AZT) 300 mg is a landmark nucleoside reverse transcriptase inhibitor (NRTI). As a pharmacist and manufacturer, I view this as a cornerstone of antiretroviral therapy (ART). It was the first breakthrough drug approved for the treatment of HIV and remains a vital component of maternal-fetal health protocols.

Primary Clinical Uses

  • HIV-1 Infection: Used in combination with other antiretroviral agents to manage and control HIV infection, reducing the viral load and increasing CD4 cell counts.

  • Prevention of Maternal-Fetal Transmission: Crucial for pregnant women living with HIV to prevent the virus from passing to the baby during pregnancy and childbirth.

  • Post-Exposure Prophylaxis (PEP): Used in emergency situations (like healthcare needle-stick injuries) to prevent HIV infection after potential exposure.

Mechanism of Action: Chain Termination

Zidovudine works by “tricking” the virus during its replication process.

Phosphorylation: Once inside the human cell, Zidovudine is converted by cellular enzymes into its active form, Zidovudine Triphosphate.

Molecular Mimicry: It structurally resembles Thymidine, one of the natural building blocks the HIV virus uses to create its DNA.

Reverse Transcriptase Inhibition: The viral enzyme, Reverse Transcriptase, mistakenly incorporates Zidovudine into the growing viral DNA chain instead of the natural thymidine.

Chain Termination: Because Zidovudine lacks the necessary chemical “hook” (the 3′-OH group) to attach the next building block, the DNA chain is terminated. The virus cannot finish copying its genetic material and fails to replicate.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Zidovudine 300 mg is a high-impact global health product:

  • The 300 mg Standard: This is the international therapeutic standard for adults. For your digital platforms, highlighting your ability to produce high-volume Fixed-Dose Combinations (FDCs)—such as Zidovudine + Lamivudine—is a major strategy for securing international NGO contracts.

  • Bone Marrow Suppression Monitoring: As a pharmacist, you know the primary side effect is anemia/neutropenia. Including technical guidance on Hematological Monitoring in your B2B dossiers and product literature builds immense professional trust.

  • Stability & Light Sensitivity: Zidovudine is sensitive to light. At our facility, we utilize Alu-Alu or Amber-colored PVC/PVDC blisters to ensure a 36-month shelf life, which is a requirement for export to Zone IVb regions.

  • Dossier & Tenders: This is a priority molecule for PEPFAR, the Global Fund, and UNAIDS. We provide full CTD/eCTD Dossiers to support your firm in bidding for these massive international supply tenders.

Zidovudine Tablet

Add to cart